American Oncology Network Statistics
Total Valuation
American Oncology Network has a market cap or net worth of 130.47 million. The enterprise value is 416.34 million.
Market Cap | 130.47M |
Enterprise Value | 416.34M |
Important Dates
The next estimated earnings date is Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
American Oncology Network has 27.10 million shares outstanding. The number of shares has increased by 93.85% in one year.
Current Share Class | n/a |
Shares Outstanding | 27.10M |
Shares Change (YoY) | +93.85% |
Shares Change (QoQ) | -64.24% |
Owned by Insiders (%) | 33.05% |
Owned by Institutions (%) | 0.09% |
Float | 18.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.03 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -28.58 |
EV / Sales | 0.26 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -9.01 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 2.72.
Current Ratio | 1.36 |
Quick Ratio | 1.05 |
Debt / Equity | 2.72 |
Debt / EBITDA | n/a |
Debt / FCF | -3.19 |
Interest Coverage | -5.27 |
Financial Efficiency
Return on equity (ROE) is -70.28% and return on invested capital (ROIC) is -11.38%.
Return on Equity (ROE) | -70.28% |
Return on Assets (ROA) | -6.16% |
Return on Capital (ROIC) | -11.38% |
Revenue Per Employee | 1.04M |
Profits Per Employee | -9,551 |
Employee Count | 1,525 |
Asset Turnover | 4.04 |
Inventory Turnover | 34.47 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.62% in the last 52 weeks. The beta is 0.34, so American Oncology Network's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | -20.62% |
50-Day Moving Average | 3.91 |
200-Day Moving Average | 3.48 |
Relative Strength Index (RSI) | 61.66 |
Average Volume (20 Days) | 4,061 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.03 |
Income Statement
In the last 12 months, American Oncology Network had revenue of 1.59 billion and -14.56 million in losses. Loss per share was -4.05.
Revenue | 1.59B |
Gross Profit | 91.45M |
Operating Income | -38.90M |
Pretax Income | -49.08M |
Net Income | -14.56M |
EBITDA | -29.36M |
EBIT | -38.90M |
Loss Per Share | -4.05 |
Balance Sheet
The company has 19.43 million in cash and 147.39 million in debt, giving a net cash position of -127.95 million or -4.72 per share.
Cash & Cash Equivalents | 19.43M |
Total Debt | 147.39M |
Net Cash | -127.95M |
Net Cash Per Share | -4.72 |
Equity (Book Value) | 54.09M |
Book Value Per Share | -7.78 |
Working Capital | 71.37M |
Cash Flow
In the last 12 months, operating cash flow was -28.83 million and capital expenditures -17.38 million, giving a free cash flow of -46.21 million.
Operating Cash Flow | -28.83M |
Capital Expenditures | -17.38M |
Free Cash Flow | -46.21M |
FCF Per Share | -1.71 |
Margins
Gross margin is 5.74%, with operating and profit margins of -2.44% and -0.57%.
Gross Margin | 5.74% |
Operating Margin | -2.44% |
Pretax Margin | -3.08% |
Profit Margin | -0.57% |
EBITDA Margin | -1.84% |
EBIT Margin | -2.44% |
FCF Margin | n/a |
Dividends & Yields
American Oncology Network does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -93.85% |
Shareholder Yield | -93.85% |
Earnings Yield | -84.14% |
FCF Yield | -35.42% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
American Oncology Network has an Altman Z-Score of 3.64.
Altman Z-Score | 3.64 |
Piotroski F-Score | n/a |